# A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency

> **NCT00883090** · PHASE2 · COMPLETED · sponsor: **CSL Behring** · enrollment: 15 (actual)

## Conditions studied

- Factor XIII Deficiency

## Interventions

- **BIOLOGICAL:** FXIII Concentrate (Human)

## Key facts

- **NCT ID:** NCT00883090
- **Lead sponsor:** CSL Behring
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883090, "A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00883090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*